Infosys Q1 Results Preview: Will IT Giant Beat Or Miss Estimates In Q1FY27? Check Stock Price Movement

Infosys Share Price

At the time of writing, Infosys stock traded at Rs 1046.60 apiece on BSE, down by 0.54% on BSE, with market cap of Rs 424,382.17 crore. The stock touched an intraday high and low of Rs 1,048 apiece and Rs 1,032.30 apiece on Wednesday. As of July 23, 2026, Infosys' price-to-equity ratio is at 14.53x and return on equity at 35.30%, as per BSE data.

Infosys ADR

Ahead of the Q1 results, Infosys' American Depositary Receipts (ADR) listed on NYSE, dropped by 2.06% to $10.93 apiece overnight.

Infosys Q1 Results Preview:

The Q1FY27 result will be most likely out after market hours on July 23, 2026, going by the past patterns.

"Infosys is expected to report revenue of ~Rs 475.5 billion, implying growth of 12.5% YoY and 2.5% QoQ. In constant currency (CC) terms, growth is projected at 3.4% YoY and 1.6% QoQ. EBITDA is estimated at Rs 111 billion, up 11.6% YoY and down 0.6% QoQ, with margins expected at 23.3%, implying a sequential contraction of ~72bps. PAT is projected at ~Rs 73.3 billion, representing growth of 6.0% YoY and a decline of 13.7% QoQ," said analysts at Yes Securities in their Q1FY27 preview note for the company.

Meanwhile, analysts at Kotak Institutional Equities believe that Infosys could report 0.9% organic revenue growth owing to seasonal strength, led by additional billing days. Growth is likely to be weaker than historic average due to macro and AI deflation headwinds.

In terms of margins, it is expected to be stable due to benefits from rupee depreciation which is expected to offset impacts of additional costs related to acquisitions.

For the order book, these analysts believe Infosys could report a large deal TCV of $2.5-2.75 billion, stable on yoy comparison.

Despite geopolitical risks and uncertain macro conditions, analysts at Kotak believes Infosys could hike its annual growth guidance at the lower end to 2% from earlier 1.5%, while keep its upper-end guidance unchanged at 3.5%.

"The revised guidance will incorporate Optimum Healthcare, which will add 120 bps to revenues. The EBIT margin guidance of 20-22% will stay unchanged," they said.

Infosys Q1 Results: Key Factors To Watch

Investors should focus on the following key factors, as per Kotak:

1. Breakdown of the impact on growth between macro and AI deflation.

2. Appetite for large transformation programs in an environment, where demand remains skewed toward cost optimization.

3. Whether advances in agentic capabilities are slowing
decision-making due to higher client caution, rather than accelerating spend.

4. The pace of conversion of GenAI programs from pilots to scaled deployments and whether these represent netnew revenue or deflation of existing work.

5. Levers to defend margins in light of high pricing pressure.

For the full year of 2025-26, Infosys delivered $20,158 million in FY '26 revenues with a growth of 3.1% in constant currency. The reported IFRS operating margin was at 20.3% and adjusted operating margin at 21.0%. EPS growth was 11.0% in rupee terms. Free cash flow generation was robust at $3,733 million. TCV of large deal wins was $14.9 billion, with net new of 55%.

In April 2026, when announcing Q4FY26 and FY26 results, Infosys announced FY27 revenue growth guidance of 1.5% to 3.5% in the constant currency. While operating margin is seen at 20-25%.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.